Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 7:14:1273587.
doi: 10.3389/fpsyt.2023.1273587. eCollection 2023.

Long-term detoxification of opioid use disorder with opium tincture assisted treatment

Sahar Omidvar Tehrani  1 , Amir Rezaei Ardani  1   2 , Saeed Akhlaghi  3 , Masood Shayesteh Zarrin  1 , Ali Talaei  1
Affiliations

Long-term detoxification of opioid use disorder with opium tincture assisted treatment

Sahar Omidvar Tehrani et al. Front Psychiatry. .

Abstract

Introduction: Retention in treatment, craving, and relapse rate are important indicators of the success rate in addiction maintenance therapy as they evaluate the effectiveness of the therapy and make necessary adjustments to the treatment plan. However, the rate of continuation in the treatment process and the rate of craving in patients with opioid use disorder undergoing maintenance treatment with opium tincture have not been studied. The present study aimed to investigate the rate of relapse, craving, and psychiatric disorders in patients with opioid use disorder undergoing treatment of gradual detoxification with opium tincture.

Methods: Ninety patients with opioid use disorder who underwent treatment with the gradual detoxification method using opium tincture in the form of Congress 60 for 11 months were enrolled in the study. The level of craving based on the Desire for Drug Questionnaire (DDQ) and patients' self-report of drug use, the level of anxiety, depression, and sleep quality of patients were evaluated using the Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI), respectively. Also, suicidal thoughts were assessed by Beck Scale for Suicidal Ideation and quality of life by the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF).

Results: The study found that the treatment resulted in a relapse rate of 16.7% for relapse. We also found that all sub-scales of the desire for drug questionnaire (DDQ), depression, and anxiety were significantly lower at the end of the study compared to its beginning. Additionally, quality of life and sleep significantly increased at the end of the study. All areas of craving, anxiety, and depression significantly decreased in all follow-up sessions that took place 1, 5, and 11 months after the start of treatment. Moreover, sleep disorders were improved considerably at the end of the treatment.

Conclusion: The current study presented a low relapse rate of Iranian patients with opioid use disorder under structured treatment of gradual detoxification with opium tincture in a one-year follow-up period. Opium tincture under the Congress 60 protocol may help to control carving, decrease psychological disorders, improve quality of life, and consequently, lower relapse rate.

Keywords: craving; detoxification; opioid use disorder; opium tincture; relapse.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of the mean scores of craving by time.
Figure 2
Figure 2
Comparison of the mean scores of anxiety by time.
Figure 3
Figure 3
Comparison of the mean scores of depression by time.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Heijdra Suasnabar JM, Hipple WB. Community-based psychosocial substance use disorder interventions in low-and-middle-income countries: a narrative literature review. Int J Ment Heal Syst. (2020) 14:74. doi: 10.1186/s13033-020-00405-3 - DOI - PMC - PubMed
    1. Naserbakht M, Djalalinia S, Tayefi B, Gholami M, Eftekhar AM, Shariat SV, et al. . National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990–2013, study protocol. Arch Iranian Med. (2014) 17:182–8. - PubMed
    1. Noorbala AA, Saljoughian A, Yazdi SAB, Faghihzadeh E, Farahzadi MH, Kamali K, et al. . Evaluation of drug and alcohol abuse in people aged 15 years and older in Iran. Iran J Public Health. (2020) 49:1940–6. doi: 10.18502/ijph.v49i10.4697, PMID: - DOI - PMC - PubMed
    1. Castaldelli-Maia JM, Bhugra D. Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int Rev Psychiatry. (2022) 34:6–15. doi: 10.1080/09540261.2022.2040450, PMID: - DOI - PubMed
    1. Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian gulf country. Asian J Psychiatr. (2015) 16:78–83. doi: 10.1016/j.ajp.2015.06.002 - DOI - PubMed

LinkOut - more resources